Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Ron-Bigger Shulamit, Chief Operating Officer of Aktis Oncology, Inc. (NASDAQ: AKTS), sold approximately $1.39 million worth of common stock on July 8, 2026, following the exercise of stock options. The transaction involved the acquisition of 50,000 shares at $3.66 per share and their subsequent sale in open market transactions ranging from $26.52 t…
Czibere Akos, the Chief Medical Officer at Aktis Oncology, Inc. (NASDAQ: AKTS), executed a series of stock transactions on July 8, 2026, resulting in the sale of 50,000 shares. The sales, totaling approximately $1.39 million, were preceded by the exercise of stock options at a significantly lower price point. Following these transactions, the execu…
American Eagle Outfitters director Noel Spiegel executed a transaction on July 7, 2026, selling 2,892 shares of common stock at a weighted average price of $16.78 per share. The transaction resulted in a total value of $48,527. Following this sale, Mr. Spiegel holds zero direct shares of the company. This divestment occurs as the retailer navigates…
American Eagle Outfitters Inc. (NASDAQ: AEO) director Cary D. McMillan executed a sale of 2,892 common shares on July 7, 2026, at a price of $16.775 per share, totaling $48,513. This transaction resulted in McMillan holding zero direct shares of the company. The sale occurred as AEO stock traded at $16.68, reflecting a 37% decline over the past six…
Nicholas S. Schorsch, a 10% owner of American Strategic Investment Co. (NASDAQ:NYC), along with affiliated entities, has executed a significant insider purchase, acquiring Class A common stock valued at $76,240. This acquisition takes place as the stock trades at $8.49, reflecting a near 9% decline over the preceding week. The transaction highlight…
Insiders tied to Stratus Properties Inc. (NASDAQ: STRS) have executed significant share sales as the company moves forward with a complete liquidation and dissolution. The transactions coincide with the firm's ongoing asset disposals, including the recent sale of the Jones Crossing retail component, and the initiation of a liquidating distribution …
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ: UTHR), sold approximately $5.24 million worth of common stock on July 9, 2026. The sale of 9,500 shares occurred after the exercise of an equal number of stock options, with prices ranging from $547.61 to $555.77 per share. The transactions were executed under a 10b5-1 t…
Insight Holdings Group, LLC and its affiliated investment funds executed a significant divestment of Hinge Health, Inc. (NASDAQ:HNGE) equity, selling a combined total of 426,171 Class A Common Stock shares. The transactions, valued at approximately $38.4 million, were completed over two trading days in July 2026. This sale activity coincides with H…
Christopher M. Hall, Chief Executive Officer of Personalis, Inc. (NASDAQ:PSNL), executed a sale of 100,000 shares of common stock on July 9, 2026, realizing approximately $1.5 million in proceeds. The transaction was facilitated through a Rule 10b5-1 trading plan, which also involved the exercise of stock options on the same day. This executive act…
Entities affiliated with Lightspeed Venture Partners, including Lightspeed Management Company and Lightspeed Venture Partners XII, executed sales of Netskope Inc. (NASDAQ:NTSK) Class A Common Stock totaling approximately $2.8 million between July 8 and July 9, 2026. These transactions followed significant internal share conversions within the Light…
CoreWeave Inc. (NASDAQ: CRWV) CEO and President Michael N. Intrator executed a series of stock sales totaling approximately $30.8 million on July 7 and July 8, 2026. The transactions, conducted under a pre-arranged Rule 10b5-1 trading plan established in November 2025, involved the liquidation of 369,489 Class A Common Stock shares. This activity c…
Jonathan M. Craig, Managing Director and Head of Retail Investing at Charles Schwab Corp. (NYSE:SCHW), executed a $2.218 million sale of 21,750 shares on July 7, 2026. The transaction, facilitated through a trust under a Rule 10b5-1 trading plan, aligns with the company's recent reporting of a 27% year-over-year increase in total client assets to $…
CoreWeave, Inc. (NASDAQ: CRWV) Chief Financial Officer Nitin Agrawal has disclosed the sale of 3 Class A Common Stock shares through a pre-arranged trading plan. The transaction, reported via a Form 4 filing with the Securities and Exchange Commission, highlights routine executive liquidity events against a backdrop of heightened analyst scrutiny a…
Nayaab Islam, President and Chief Product Officer at StubHub Holdings, Inc., executed a stock sale involving 2,800 shares of the company's Class A Common Stock on July 7, 2026. The transaction, valued at approximately $39,214, was conducted under a pre-existing Rule 10b5-1 trading plan adopted earlier in the year. This divestment follows a period o…
Mark Streams, Executive Vice Chairman and Chief Legal Officer at StubHub Holdings, Inc. (NASDAQ: STUB), executed a sale of 400 shares of the company's Class A Common Stock on July 7, 2026. The transaction, valued at $5,603, was conducted under a Rule 10b5-1 trading plan established in December 2025. Following the sale, Streams retains a direct hold…
CrowdStrike Holdings, Inc. CEO George Kurtz sold approximately $3.86 million worth of Class A common stock over July 7 and 8, 2026. The transactions were executed under a pre-arranged 10b5-1 trading plan established earlier in the year. The sale follows a period of strong stock performance and a quarterly earnings report that surpassed revenue expe…
Multiple Lightspeed-affiliated investment vehicles executed a coordinated series of transactions involving Netskope Inc (NASDAQ:NTSK) equity, resulting in the liquidation of approximately $2.8 million in Class A Common Stock. The filings, submitted to the Securities and Exchange Commission, detail sales occurring on July 8 and July 9, 2026, alongsi…
Bernhard L. Kohn III, Chief Executive Officer and President of Playboy, Inc. (NASDAQ: PLBY), executed sales of 324,453 shares of the company's common stock between July 7 and July 9, 2026. The transactions, totaling approximately $375,098, were designated to cover tax withholding obligations associated with the settlement of previously granted rest…
AppFolio Inc. (NASDAQ: APPF) 10% shareholder Maurice J. Duca sold approximately $1.93 million worth of Class A Common Stock on July 7, 2026. The transactions were executed under a pre-arranged 10b5-1 trading plan adopted in March 2026. Despite the insider activity, the company reported strong first-quarter earnings, surpassing expectations with 21%…
Edward Smolyansky, a significant shareholder in Lifeway Foods, executed recent sales of company stock valued at approximately $1.39 million. The transactions occurred as the stock trades near its annual peak, despite the company reporting earnings that beat consensus estimates. Analyst sentiment remains split, with one firm downgrading the stock wh…
Jonathan Yen-Wen Yu, Chief Operating Officer of Disc Medicine, Inc. (NASDAQ:IRON), executed a transaction involving the sale of 100 shares of the company's common stock on July 7, 2026. The shares were disposed of at a price of $82.50 each, resulting in a total transaction value of $8,250. This sale was part of a broader sequence of events that inc…
C. Frank Bennett, serving as Executive Vice President and Chief Scientific Officer at Ionis Pharmaceuticals Inc. (NASDAQ:IONS), executed the sale of common stock valued at approximately $1.74 million on July 7, 2026. The transactions, conducted under a Rule 10b5-1 trading plan established in March 2026, involved both directly and indirectly held sh…
Abeona Therapeutics CEO Seshadri Vishwas sold approximately $473,329 worth of company shares on July 9, 2026, to cover tax obligations from restricted stock vesting. The sale occurs as the stock trades near its 52-week high, following a strong first-quarter earnings report that beat analyst expectations on both revenue and earnings per share.
Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics Inc., sold 24,880 shares on July 9, 2026, generating $173,256 to cover tax liabilities from restricted stock vesting. The transaction occurred at prices between $6.86 and $7.04 per share, with a weighted average of $6.9637. This sale reduces his direct holdings to 493,557 shares.…
Brendan M. O’Malley, Senior Vice President and Chief Legal Officer at Abeona Therapeutics Inc. (NASDAQ: ABEO), executed a sale of 12,050 shares of the company's common stock on July 9, 2026. The transaction, valued at $83,912, was conducted to satisfy tax liabilities arising from the vesting of restricted stock awards. This sale occurs as ABEO stoc…
